These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 24597439)
1. Levels of Recovery Scale (LORS): psychometric properties of a new instrument to assess psychotic symptoms and patient awareness. Corriveau DP; Sousa S Psychol Rep; 2013 Oct; 113(2):435-40. PubMed ID: 24597439 [TBL] [Abstract][Full Text] [Related]
2. The LORS-enabled dialogue: a collaborative intervention to promote recovery from psychotic disorders. Sousa SA; Corriveau D; Lee AF; Bianco LG; Sousa GM Psychiatr Serv; 2013 Jan; 64(1):58-64. PubMed ID: 23117253 [TBL] [Abstract][Full Text] [Related]
3. [Relationship between insight and self-reported quality of life among shizophrenic patients]. Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Illness Management and Recovery Scale in schizophrenia and schizoaffective disorder. Färdig R; Lewander T; Fredriksson A; Melin L Schizophr Res; 2011 Nov; 132(2-3):157-64. PubMed ID: 21798718 [TBL] [Abstract][Full Text] [Related]
5. [Insight in schizophrenia: assessment of 31 patients with different scales]. Travers D; Levoyer D; Millet B Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153 [TBL] [Abstract][Full Text] [Related]
6. Psychometric evaluation of the Psychotic Symptom Rating Scales. Kronmüller KT; von Bock A; Grupe S; Büche L; Gentner NC; Rückl S; Marx J; Joest K; Kaiser S; Vedder H; Mundt C Compr Psychiatry; 2011; 52(1):102-8. PubMed ID: 21220071 [TBL] [Abstract][Full Text] [Related]
7. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms. Selten JP; Wiersma D; van den Bosch RJ Compr Psychiatry; 2000; 41(3):191-6. PubMed ID: 10834628 [TBL] [Abstract][Full Text] [Related]
8. Measurement of insight in patients with bipolar disorder: are self-rated scales developed for patients with schizophrenia applicable? Jónsdóttir H; Engh JA; Friis S; Birkenaes A; Ringen PA; Vaskinn A; Sundet K; Opjordsmoen S; Andreassen OA J Nerv Ment Dis; 2008 Apr; 196(4):333-5. PubMed ID: 18414129 [TBL] [Abstract][Full Text] [Related]
9. The Subjective Experiences of Psychosis Scale (SEPS): psychometric evaluation of a scale to assess outcome in psychosis. Haddock G; Wood L; Watts R; Dunn G; Morrison AP; Price J Schizophr Res; 2011 Dec; 133(1-3):244-9. PubMed ID: 22000941 [TBL] [Abstract][Full Text] [Related]
10. A new rating scale for negative symptoms: the Motor-Affective-Social Scale. Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021 [TBL] [Abstract][Full Text] [Related]
11. Validation and use of the functioning assessment short test in first psychotic episodes. González-Ortega I; Rosa A; Alberich S; Barbeito S; Vega P; Echeburúa E; Vieta E; González-Pinto A J Nerv Ment Dis; 2010 Nov; 198(11):836-40. PubMed ID: 21048476 [TBL] [Abstract][Full Text] [Related]
12. [Psychometric properties of the French version of the signs and symptoms of psychotic illness (SSPI) scale]. Houenou J; Szöke A; Méary A; Loze JY; Mathieu F; Leboyer M; Schürhoff F Encephale; 2007 Oct; 33(5):744-50. PubMed ID: 18357844 [TBL] [Abstract][Full Text] [Related]
13. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Computerized Adaptive Assessment Tool for Discrimination and Measurement of Psychotic Symptoms. Guinart D; de Filippis R; Rosson S; Patil B; Prizgint L; Talasazan N; Meltzer H; Kane JM; Gibbons RD Schizophr Bull; 2021 Apr; 47(3):644-652. PubMed ID: 33164091 [TBL] [Abstract][Full Text] [Related]
16. [Minor neurological and physical anomalies in patients with first-episode psychosis]. Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597 [TBL] [Abstract][Full Text] [Related]
17. Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms. Dollfus S; Mach C; Morello R Schizophr Bull; 2016 May; 42(3):571-8. PubMed ID: 26564898 [TBL] [Abstract][Full Text] [Related]
18. Insight, symptomatic dimensions, and cognition in patients with acute-phase psychosis. Nieto L; Cobo J; Pousa E; Blas-Navarro J; García-Parés G; Palao D; Obiols JE Compr Psychiatry; 2012 Jul; 53(5):502-8. PubMed ID: 22036010 [TBL] [Abstract][Full Text] [Related]
19. Delusional experience awareness gap between patients and treating doctors - Self-reported EPDS questionnaire. Kanemoto K; Tsuda H; Goji H; Tadokoro Y; Oshima T; Tachimori H; DeToffol B Epilepsy Behav; 2015 Oct; 51():60-4. PubMed ID: 26262934 [TBL] [Abstract][Full Text] [Related]
20. Psychometric evaluation of the Temporal Experience of Pleasure Scale (TEPS) in a German sample. Simon JJ; Zimmermann J; Cordeiro SA; Marée I; Gard DE; Friederich HC; Weisbrod M; Kaiser S Psychiatry Res; 2018 Feb; 260():138-143. PubMed ID: 29195165 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]